Research ArticleArticle
The Risk of Tuberculosis in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Antagonist: A Metaanalysis of Both Randomized Controlled Trials and Registry/Cohort Studies
Jing-Wen Ai, Shu Zhang, Qiao-Ling Ruan, Yi-Qi Yu, Bing-Yan Zhang, Qi-Hui Liu and Wen-Hong Zhang
The Journal of Rheumatology December 2015, 42 (12) 2229-2237; DOI: https://doi.org/10.3899/jrheum.150057
Jing-Wen Ai
From the Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai,
China.
Shu Zhang
Qiao-Ling Ruan
Yi-Qi Yu
Bing-Yan Zhang
Qi-Hui Liu
Wen-Hong Zhang
Data supplements
Data Supplement
Data Supplement
Files in this Data Supplement:
- Data Supplement - Data Supplement
In this issue
The Journal of Rheumatology
Vol. 42, Issue 12
1 Dec 2015
The Risk of Tuberculosis in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Antagonist: A Metaanalysis of Both Randomized Controlled Trials and Registry/Cohort Studies
Jing-Wen Ai, Shu Zhang, Qiao-Ling Ruan, Yi-Qi Yu, Bing-Yan Zhang, Qi-Hui Liu, Wen-Hong Zhang
The Journal of Rheumatology Dec 2015, 42 (12) 2229-2237; DOI: 10.3899/jrheum.150057
The Risk of Tuberculosis in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Antagonist: A Metaanalysis of Both Randomized Controlled Trials and Registry/Cohort Studies
Jing-Wen Ai, Shu Zhang, Qiao-Ling Ruan, Yi-Qi Yu, Bing-Yan Zhang, Qi-Hui Liu, Wen-Hong Zhang
The Journal of Rheumatology Dec 2015, 42 (12) 2229-2237; DOI: 10.3899/jrheum.150057